Interaction of an intercalating antitumoral agent: 9-hydroxy-2-methyl ellipticinium (NMHE) with chromatin.
In this work we study the effects of an intercalating antitumoral agent: 9-hydroxy-2-methyl ellipticinium (NMHE) on the structure of chromatin, using micrococcal nuclease and DNase 1 as structural probes. The binding of the drug to chromatin, either in vitro or in the nuclei, induces two structural changes of chromatin: (a) an unfolding of the overall structure which results in an activation of the rate of degradation of chromatin by micrococcal nuclease and (b) a disorganisation of the core particle structure leading to the unwrapping of the DNA from the histone core. Moreover, by studying the interaction of MMHE with nuclei labeled in the active regions of the genome through a nick-translation reaction, it appears that the drug is overconcentrated in these regions and does not induce any new structural changes. The interaction of NMHE with DNase 1-sensitive regions of chromatin indicates that these regions are already "open" or relaxed and represent a preferential target for the drug.
Larue
L
L
INSERM U140, Institut Gustave-Roussy, Villejuif, France.
Quesne
M
M
Paoletti
J
J
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002467:Cell Nucleus / Q000378:metabolism; D002645:Chickens; D002843:Chromatin / Q000187:drug effects* / Q000378:metabolism; D004247:DNA / Q000378:metabolism; D003850:Deoxyribonuclease I / Q000494:pharmacology; D004611:Ellipticines / Q000378:metabolism / Q000494:pharmacology*; D066298:In Vitro Techniques; D007364:Intercalating Agents / Q000494:pharmacology*; D008836:Micrococcal Nuclease / Q000494:pharmacology
D000470:Alkaloids; D000970:Antineoplastic Agents; D002843:Chromatin; D004611:Ellipticines; D007364:Intercalating Agents; C027767:elliptinium; D004247:DNA; D003850:Deoxyribonuclease I; D008836:Micrococcal Nuclease